WASHINGTON, Sept. 1 -- The American Brain Coalition, Maple Grove, Minnesota, has expressed strong support for the ongoing Medical Device User Fee Amendments (MDUFA) process in a public comment letter to the U.S. Food and Drug Administration (FDA). The organization emphasizes the importance of patient advocacy and collaboration in advancing innovation within the realm of neurotechnology and medical devices aimed at improving the lives of those affected by brain disorders. In the letter submitted  more